Skip to main content

Lower Rate of Complications Seen With Recent Abdominoplasties

Medically reviewed by Carmen Pope, BPharm. Last updated on Dec 29, 2023.

By Elana Gotkine HealthDay Reporter

THURSDAY, Dec. 28, 2023 -- In recent years, the rates of complications and revision surgery for abdominoplasties have decreased, according to a study published in the January issue of Plastic and Reconstructive Surgery.

Michael J. Stein, M.D., from Lenox Hill Hospital in New York City, and colleagues examined trends in practice patterns for abdominoplasty based on a 16-year review of tracer data from 2005 to 2021. The patients were split into an early cohort (EC; 2005 to 2014) and recent cohort (RC; 2015 to 2021) to facilitate comparison of an equal number of patients over time. Data were included from 8,990 abdominoplasties (EC: 4,740; RC: 4,250).

The researchers found that the rate of complications was lower for RC than EC abdominoplasties (19 versus 22 percent) and the rate of revision surgery was also lower (8 versus 10 percent). This occurred despite the use of abdominal flap liposuction increasing (25 versus 18 percent). Use of wide undermining, vertical plication of the abdomen, and surgical drains all decreased significantly. Outpatient abdominoplasty surgery is increasingly performed, with increased chemoprophylaxis for prevention of thrombosis.

"Abdominoplasty has remained a safe and reliable procedure over the 16-year study period, with a slight but statistically significant decrease in adverse events in the RC," the authors write. "Careful preoperative evaluation of patients should identify risk factors that increase the risk of complications."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Perioperative Chemo Improves Progression-Free Survival in Pancreatic Cancer

TUESDAY, July 2, 2024 -- For patients with resectable pancreatic ductal adenocarcinoma (PDAC), the 12-month progression-free survival (PFS) may be increased with neoadjuvant...

Few Patients With Positive Margins After Basal Cell Excision Have Recurrence

MONDAY, July 1, 2024 -- Among patients with incompletely excised basal cell carcinoma (BCC), only about 16 percent with positive histopathologic margins have clinical recurrence...

Bariatric Surgery Tied to Lower Risk of MACE, Death in Obesity, Sleep Apnea

FRIDAY, June 28, 2024 -- Metabolic surgery is associated with significantly lower risk of major adverse cardiovascular events (MACE) compared with nonsurgical management among...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.